首页 | 本学科首页   官方微博 | 高级检索  
     


Manganese chelation therapy extends survival in a mouse model of M1000 prion disease
Authors:Marcus W. Brazier  Irene Volitakis  Magda Kvasnicka  Anthony R. White  John R. Underwood  Jason E. Green  Sen Han  Andrew F. Hill  Colin L. Masters  Steven J. Collins
Affiliation:1. Department of Pathology, The University of Melbourne, Victoria, Australia 3010;2. Mental Health Research Institute, Parkville, Victoria, Australia 3010;3. Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia;4. Department of Biochemistry and Molecular Biology and the Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia 3010;5. Australian National Creutzfeldt‐Jakob Disease Registry, University of Melbourne, Victoria, Australia 3010
Abstract:
Keywords:chelation therapy  cyclohexanediaminetetraacetic acid  manganese  neurodegeneration  prion disease  transmissible spongiform encephalopathy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号